Seres Therapeutics Reports Third Quarter 2024 Financial Results and[...]
Acurx Pharmaceuticals, Inc. Reports Third Quarter 2024 Results and[...]
Quarterly Report for Quarter Ending September 30, 2024 (Form 10-Q)
11/13/2024 | News release | Distributed by Public on 11/13/2024 06:07
Please select the service you want to use:
Smartlinks | Dover Corporation | News | Local News | Company News | Conference Calls and Webcasts | Securities Issuers | Industrial Equipment and Components Manufacturers | London Stock Exchange (LSE) | New York Stock Exchange (NYSE) | Frankfurt Stock Exchange | Sao Paulo Stock Exchange (B3) | Berlin Stock Exchange | Dusseldorf Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | Moscow Exchange (MOEX) | BX Swiss | Tradegate Exchange | XETRA | NYSE American | NYSE ARCA Equities | Cboe BZX Exchange | Cboe Off Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | FINRA Alternative Display Facility (ADF) | Investors Exchange (IEX) | Hannover Stock Exchange | Nasdaq BX | Nasdaq Intermarket | Nasdaq PSX | NYSE Chicago
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact